Amphastar Pharmaceuticals, Inc. (AMPH)

Last Closing Price: 19.34 (2026-03-06)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amphastar Pharmaceuticals, Inc. (AMPH) had Net Income of $98.09M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$719.89M
Net Income
$98.09M
$363.83M
$356.06M
$579.48M
$140.40M
$-16.78M
$123.62M
$123.62M
$98.09M
$98.09M
$98.09M
$98.09M
$140.40M
$200.45M
46.74M
48.22M
$2.10
$2.03
Balance Sheet Financials
$636.02M
$310.57M
$993.28M
$1.63B
$158.16M
$608.75M
$682.34M
$840.49M
$788.80M
$222.84M
$788.80M
45.65M
Cash Flow Statement Financials
$156.12M
$-70.33M
$-67.42M
$151.84M
$170.41M
$18.57M
$27.28M
--
--
Fundamental Metrics & Ratios
4.02
--
--
0.44
0.77
49.46%
19.50%
19.50%
27.85%
17.17%
13.63%
$121.23M
--
--
--
0.44
2.06
4.48
81.49
12.44%
44.02%
6.02%
7.02%
$17.28
$2.51
$3.24